By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genome engineering firm Cellectis and the Center for iPS Cells Research and Application of Kyoto University today announced a collaboration to combine their technologies to develop induced pluripotent stem cells, or iPS, as cellular tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.